Skip to main content

Testolactone Pregnancy and Breastfeeding Warnings

Brand names: Teslac

Testolactone Pregnancy Warnings

Testolactone has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of increased fetal mortality, increased abnormal fetal development, and increased mortality. There are no controlled data in human pregnancy. Testolactone is intended for use only in postmenopausal women. This drug is not recommended for use during pregnancy.

See references

Testolactone Breastfeeding Warnings

There are no data on the excretion of testolactone into human milk. Testolactone is intended for use only in postmenopausal women. If the physician does wish to use this medication in a lactating women, it should be taken into account that because many drugs are excreted in human milk and because of the potential for serious adverse reactions due to testolactone in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. (2001) "Product Information. Teslac (testolactone)." Bristol-Myers Squibb

References for breastfeeding information

  1. (2001) "Product Information. Teslac (testolactone)." Bristol-Myers Squibb

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.